Quantitative Systematic Strategies’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,597
Closed -$899K 56
2021
Q2
$899K Sell
2,597
-156
-6% -$47.3K 0.31% 87
2021
Q1
$770K Buy
2,753
+18
+0.7% +$4.85K 0.12% 281
2020
Q4
$670K Sell
2,735
-168
-6% -$43.3K 0.09% 326
2020
Q3
$824K Buy
2,903
+979
+51% +$273K 0.14% 213
2020
Q2
$515K Buy
1,924
+1,205
+168% +$362K 0.1% 296
2020
Q1
$227K Sell
719
-3,238
-82% -$983K 0.19% 193
2019
Q4
$1.17M Buy
+3,957
New +$1.1M 0.17% 178
2017
Q3
Sell
-1,056
Closed -$287K 455
2017
Q2
$287K Buy
+1,056
New +$279K 0.07% 326
2016
Q4
Sell
-4,627
Closed -$1.42M 310
2016
Q3
$1.42M Buy
4,627
+52
+1% +$15.4K 0.52% 46
2016
Q2
$1.09M Buy
4,575
+1,681
+58% +$443K 0.51% 27
2016
Q1
$736K Sell
2,894
-2,433
-46% -$643K 0.28% 146
2015
Q4
$1.64M Buy
+5,327
New +$1.53M 0.45% 3
2015
Q3
Sell
-3,602
Closed -$1.43M 374
2015
Q2
$1.43M Buy
+3,602
New +$1.45M 0.32% 89
2014
Q1
Sell
-979
Closed -$274K 285
2013
Q4
$274K Buy
+979
New +$253K 0.22% 157

Other funds holding BIIB

Quantitative Systematic Strategies's BIIB Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Biogen (BIIB) in Q3 2021, closing a stake of 2,597 shares — an estimated $899K sold.

Quantitative Systematic Strategies first reported a position in BIIB in Q4 2013 and held it in 14 quarters. The position peaked at $1.64M in Q4 2015. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 2,597 Biogen shares in Q3 2021, an estimated $899K.
  • Quantitative Systematic Strategies first reported a position in Biogen in Q4 2013 and held it in 14 quarters.
  • Quantitative Systematic Strategies's Biogen position peaked at $1.64M in Q4 2015.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.